SEC Form 4 · accession 0001209191-16-142151
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt M Eichler
Director
Period of report
Sep 16, 2016
Accepted (ET)
Sep 20, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 16, 2016 | P | 650 | $12.50 | A | 429,644 | D | |
| Common Stock | Sep 19, 2016 | P | 1,346 | $12.50 | A | 430,990 | D |
Table II — derivative securities
No Table II lines on this filing.